Vinblastine + Tolterodine Tartrate Interaction
Moderateinteraction on record
Description
CYP3A4 inhibitor that may increase tolterodine plasma concentrations. Dose reduction to 1 mg twice daily is recommended.
Mechanism
CYP3A4 inhibition
Source: NLP:tolterodine tartrate